Literature DB >> 11834678

COPD and osteoporosis.

Diane M Biskobing1.   

Abstract

Osteoporosis, with resulting fractures, is a significant problem in patients with advanced COPD. The etiology for the bone loss is diverse but includes smoking, vitamin D deficiency, low body mass index, hypogonadism, sedentary lifestyle, and use of glucocorticoids. Effective strategies to prevent bone loss and/or to treat osteoporosis include calcium and vitamin D, hormone replacement when indicated, calcitonin, and bisphosphonate administration. However, many patients remain undiagnosed until their first fracture because of the lack of recognition of the disease. With an increased awareness by pulmonologists and the increased use of preventive strategies, the impact of osteoporosis on those patients with COPD should decrease.

Entities:  

Mesh:

Year:  2002        PMID: 11834678     DOI: 10.1378/chest.121.2.609

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  55 in total

Review 1.  Skeletal Implications of Chronic Obstructive Pulmonary Disease.

Authors:  Barbara M Misof; Carolina A Moreira; Klaus Klaushofer; Paul Roschger
Journal:  Curr Osteoporos Rep       Date:  2016-04       Impact factor: 5.096

2.  What is (and what is not) a COPD exacerbation: thoughts from the new GOLD guidelines.

Authors:  J R Hurst; J A Wedzicha
Journal:  Thorax       Date:  2007-03       Impact factor: 9.139

3.  Clinician's Commentary on Roig et al.(1).

Authors:  Marla Beauchamp
Journal:  Physiother Can       Date:  2011-10-20       Impact factor: 1.037

4.  COPD as an independent risk factor for osteoporosis and fractures.

Authors:  M G Adas-Okuma; S S Maeda; M R Gazzotti; C M Roco; C O Pradella; O A Nascimento; E F Porto; J G H Vieira; J R Jardim; M Lazaretti-Castro
Journal:  Osteoporos Int       Date:  2019-12-06       Impact factor: 4.507

5.  Osteoporosis and the risk of temporomandibular disorder in chronic obstructive pulmonary disease.

Authors:  Kuei-Chen Lee; Yung-Tsan Wu; Wu-Chien Chien; Chi-Hsiang Chung; Chih-Hao Shen; Liang-Cheng Chen; Yi-Shing Shieh
Journal:  J Bone Miner Metab       Date:  2020-07-28       Impact factor: 2.626

6.  A novel distal enhancer mediates cytokine induction of mouse RANKl gene expression.

Authors:  Kathleen A Bishop; Mark B Meyer; J Wesley Pike
Journal:  Mol Endocrinol       Date:  2009-10-30

7.  Association between vitamin D status and COPD phenotypes.

Authors:  Mia Moberg; Thomas Ringbaek; Nassim Bazeghi Roberts; Jørgen Vestbo
Journal:  Lung       Date:  2014-04-20       Impact factor: 2.584

8.  Incidence of hospitalized osteoporotic fractures in cohorts with high dietary intake of persistent organochlorine compounds.

Authors:  Ann-Kathrine Alveblom; Lars Rylander; Olof Johnell; Lars Hagmar
Journal:  Int Arch Occup Environ Health       Date:  2003-02-12       Impact factor: 3.015

Review 9.  Targeted treatment in COPD: a multi-system approach for a multi-system disease.

Authors:  David Anderson; William Macnee
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-09-01

Review 10.  Long-term therapy in COPD: any evidence of adverse effect on bone?

Authors:  Arnulf Langhammer; Siri Forsmo; Unni Syversen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-10-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.